Follow-The-Filings

ASND Ascendis Pharma A/S

Health Care SPONSORED ADR Equity as of 2026 Q2 among managers we track

  • 3 exits

ASND (Ascendis Pharma A/S) 13F ownership among featured managers we track as of 2026 Q2. In 2026 Q2 filings, 3 managers sold out. Figures are as-filed 13F, not free float.

Who owns ASND

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Nathan Fischel - Dafna Capital Management exited 2026 Q2 Last 2026 Q1 1.2% Exit −1.21% 23,177 $5M History
Ron Baron - Bamco Inc. (Baron Capital) exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 5,600 $1M History
Polen Capital Management exited 2026 Q2 Last 2026 Q1 <0.01% Exit 0.00% 1,812 $414K History

0 current · 3 exited last period · options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 8 rows shown

Filed Form Detail Links
4 Period Apr 14, 2026 Filing Doc
4 Period Sep 8, 2026 Filing Doc
4 Period Sep 2, 2026 Filing Doc
4 Period Aug 14, 2026 Filing Doc
4 Period Jun 2, 2026 Filing Doc
4 Period May 29, 2026 · 2 forms Filing Doc
4 Period May 26, 2026 Filing Doc
4 Period May 11, 2026 Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

Ownership over time

filing count by report period · click a bar for that quarter’s holders